U.S. market Closed. Opens in 11 hours 55 minutes

ACAD | ACADIA Pharmaceuticals Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-312001-12-312000-12-31
Revenue726.44M517.24M484.14M441.75M339.08M223.81M124.90M17.33M61.00K120.00K1.15M4.91M2.07M42.13M6.40M1.59M7.55M8.13M10.96M4.60M7.38M6.28M3.71M4.31M
Cost of Revenue45.73M10.17M19.14M20.55M19.60M18.33M13.06M4.41MN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Gross Profit680.71M507.07M465.00M421.20M319.48M205.48M111.84M12.93MN/AN/AN/AN/A2.07M42.13M6.40M1.59MN/AN/AN/AN/AN/AN/AN/AN/A
Operating Expenses754.09M730.66M635.44M707.79M566.02M452.92M404.25M285.74M164.67M93.35M39.44M25.79M24.92M27.04M51.87M68.57M70.21M57.19M46.76M30.70M21.12M18.90M18.99M15.58M
Selling, General & Admin402.47M369.09M396.03M388.66M325.64M265.76M255.06M186.46M90.80M32.75M12.72M7.00M7.61M6.46M10.28M11.82M12.27M11.35M15.91M7.25M4.18M3.98M3.76M3.00M
Research & Development351.62M361.57M239.41M319.13M240.38M187.16M149.19M99.28M73.87M60.60M26.72M18.79M17.31M20.58M41.59M56.75M57.94M49.40M30.85M23.45M16.93M14.92M13.09M9.73M
Other Operating Expenses5.11M3.54M2.33M-997.00K997.00K-1.84MN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A-3.56MN/AN/AN/AN/A2.15M2.85M
Operating Income-73.38M-223.60M-170.44M-286.59M-246.54M-247.44M-292.41M-272.81M-164.61M-93.23M-38.30M-20.89M-22.85M15.09M-45.47M-66.98M-62.65M-49.05M-35.81M-26.10M-13.74M-12.63M-15.28M-11.27M
Other Expenses / Income22.34M10.15M2.92M5.61M12.16M-1.84M4.13M2.76M499.00K755.00K349.00K37.00KN/AN/AN/AN/AN/A3.56MN/AN/AN/AN/AN/AN/A
Before Tax Income-51.04M-213.44M-167.52M-280.97M-234.38M-243.94M-288.28M-270.05M-164.11M-92.47M-37.95M-20.85MN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Income Tax Expenses10.25M2.53M351.00K611.00K876.00K1.26M1.12M1.34M330.00KN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Net Income-61.29M-215.97M-167.87M-281.58M-235.26M-245.19M-289.40M-271.39M-164.44M-92.47M-37.95M-20.85M-22.77M15.14M-45.15M-64.24M-56.39M-45.05M-34.14M-25.92M-14.09M-12.87M-14.41M-10.19M
Interest ExpensesN/A6.61MN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A86.00K181.00KN/AN/AN/AN/AN/AN/AN/AN/A
Basic Shares Outstanding163.82M161.68M160.49M157.33M147.20M126.58M122.60M115.86M100.63M97.25M85.72M55.12M52.18M38.59M37.48M37.11M35.21M27.92M22.01M10.35M1.46M1.45M1.21M1.07M
Diluted Shares Outstanding163.82M161.68M160.49M157.33M147.20M126.58M122.60M115.86M100.63M97.25M85.72M55.12M52.18M38.72M37.48M37.11M35.21M27.92M22.01M10.35M11.37M1.45M1.21M1.07M
EBITDA-67.83M-223.60M-170.44M-286.59M-246.54M-247.44M-285.57M-268.22M-163.47M-92.27M-37.87M-20.74M-22.48M15.75M-43.95M-63.02M-55.62M-45.19M-33.11M-24.61M-12.75M-11.47M-14.41M-10.19M
EBITDA Margin-9.34%-43.23%-35.20%-64.87%-72.71%-110.56%-228.64%-1,547.65%-267,977.05%-76,890.83%-3,307.34%-422.66%-1,087.57%37.37%-686.79%-3,963.52%-736.23%-555.69%-302.20%-534.53%-172.79%-182.70%-387.88%-236.41%
EBIT-51.04M-206.83M-167.52M-280.97M-234.38M-243.94M-288.28M-270.05M-164.11M-92.47M-37.95M-20.85M-22.77M15.14M-45.06M-64.06M-56.39M-45.05M-34.14M-25.92M-14.09M-12.87M-14.41M-10.19M
EBIT Margin-7.03%-39.99%-34.60%-63.60%-69.12%-108.99%-230.81%-1,558.20%-269,037.70%-77,062.50%-3,314.24%-424.88%-1,101.35%35.93%-704.16%-4,029.12%-746.39%-553.89%-311.56%-562.89%-191.00%-205.05%-387.88%-236.41%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-312001-12-312000-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙